Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03088904
What this trial is testing

Genetic and Environmental Factors in the Response to Influenza Vaccination

Who this might be right for
InfluenzaHealthy
Stanford University 109
Early research (Phase 1)Study completedNCT00310206
What this trial is testing

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Large-scale testing (Phase 3)Study completedNCT05044195
What this trial is testing

A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age

Who this might be right for
Influenza, Human
Seqirus 2,044
Testing effectiveness (Phase 2)Study completedNCT03755427
What this trial is testing

An Adjuvanted Inactivated H7N9 Influenza Vaccine

Who this might be right for
H7N9 Influenza
Shanghai Institute Of Biological Products 560
Not applicableStudy completedNCT01394614
What this trial is testing

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Who this might be right for
Narcolepsy
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 24
Large-scale testing (Phase 3)Study completedNCT02154308
What this trial is testing

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 787
Post-approval studies (Phase 4)Study completedNCT03023176
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013

Who this might be right for
Influenza
Stanford University 20
Early research (Phase 1)Study completedNCT03312699
What this trial is testing

Effects of Aging on Primary and Secondary Vaccine Responses

Who this might be right for
InfluenzaHepatitis ATyphoid+1 more
Stanford University 54
Large-scale testing (Phase 3)Study completedNCT04210349
What this trial is testing

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 7,106
Post-approval studies (Phase 4)Study completedNCT03101462
What this trial is testing

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Who this might be right for
Influenza
St. Louis University 38
Post-approval studies (Phase 4)Study completedNCT02104869
What this trial is testing

Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients

Who this might be right for
Human Influenza
Butantan Institute 195
Large-scale testing (Phase 3)Study completedNCT05312294
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

Who this might be right for
InfluenzaFlu, Human
St. Petersburg Research Institute of Vaccines and Sera 654
Large-scale testing (Phase 3)Study completedNCT03704740
What this trial is testing

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Who this might be right for
Influenza
SK Bioscience Co., Ltd. 676
Large-scale testing (Phase 3)Study completedNCT01640314
What this trial is testing

Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
Novartis Vaccines 126
Large-scale testing (Phase 3)Study completedNCT03460743
What this trial is testing

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Who this might be right for
Influenza, Human
Laboratorios Liomont 1,556
Testing effectiveness (Phase 2)Study completedNCT00775450
What this trial is testing

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

Who this might be right for
InfluenzaOrthomyxovirus InfectionMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 807
Post-approval studies (Phase 4)Study completedNCT02269852
What this trial is testing

The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 182
Large-scale testing (Phase 3)Study completedNCT05431725
What this trial is testing

Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,202
Testing effectiveness (Phase 2)Study completedNCT00329927
What this trial is testing

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Who this might be right for
Influenza
Novartis 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation